Neuroimaging in Parkinson's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 70, 2006, Pages 241-248

  Au, W Lok ^a   Adams, J R ^a   Troiano, A ^a   Stoessl, A J ^a  

^a Pacific Parkinson's Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; CARBON 11; FLUORODEOXYGLUCOSE F 18; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PARKIN;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN SIZE; CONFERENCE PAPER; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DOPAMINERGIC SYSTEM; DYSTONIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE MUTATION; HUMAN; IDIOPATHIC DISEASE; NEUROCHEMISTRY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VOLUMETRY;

DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MOVEMENT DISORDERS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; SUBSTANTIA NIGRA;

EID: 33750321936     PISSN: 03036995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Aasly JO, Toft M, Fernandez-Mata I, Kachergus J, Hulihan M, White LR et al. (2005) Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann Neurol 57: 762-765
2. Adams JR, van Netten H, Schulzer M, Mak E, McKenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ (2005) PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain 128: 2777-2785
3. Antonini A, Moresco RM, Gobbo C, De Notaris R, Panzacchi A, Barone P et al. (2002) Striatal dopaminergic denervation in early and late onset Parkinson's disease assessed by PET and the tracer [11C]FECIT: preliminary findings in one patient with autosomal recessive parkinsonism (Park2). Neurol Sci 23 [Suppl 2]: S51-S52
4. Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, Tishler TA, Marder SR, Mintz J (1999) MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 17: 213-222
5. Bhattacharya K, Saadia D, Eisenkraft B, Yahr M, Olanow W, Drayer B, Kaufmann H (2002) Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease - a diagnostic algorithm. Arch Neurol 59: 835-842
6. Brenneis C, Seppi K, Schocke MF, Muller J, Luginger E, Bosch S, Loscher WN, Buchel C, Poewe W, Wenning GK (2003) Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 18: 1132-1138
7. Carbon M, Kingsley PB, Su S, Smith GS, Spetsieris P, Bressman S, Eidelberg D (2004) Microstructural white matter changes in carriers of the DYT1 gene mutation. Ann Neurol 56: 283-286
8. Di Fonzo A, Rohe CF, Ferreira J, Chien HF, Vacca L, Stocchi F et al. (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365: 412-415
9. Eckert T, Sailer M, Kaufmann J, Schrader C, Peschel T, Bodammer N, Heinze HJ, Schoenfeld MA (2004) Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 21: 229-235
10. Fearnley JM, Lees AJ (1991) Aging and Parkinson's disease - substantia nigra regional selectivity. Brain 114: 2283-2301
11. Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ et al. (2005) A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365: 415-416
12. Hanyu H, Asano T, Sakurai H, Takasaki M, Shindo H, Abe K (2001) Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy. Neuroradiology 43: 542-546
13. Haslinger B, Erhard P, Kampfe N, Boecker H, Rummeny E, Schwaiger M, Conrad B, Ceballos-Baumann AO (2001) Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 124: 558-570
14. Hernandez DG, Paisan-Ruiz C, McInerney-Leo A, Jain S, Meyer-Lindenberg A, Evans EW et al. (2005) Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Ann Neurol 57: 453-456
15. Hilker R, Klein C, Ghaemi M, Kis B, Strotmann T, Ozelius LJ et al. (2001) Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol 49: 367-376
16. Hu MTM, White SJ, Herlihy AH, Chaudhuri KR, Hajnal JV, Brooks DJ (2001) A comparison of F-18-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. Neurology 56: 1195-1200
17. Hutchinson M, Raff U (1999) Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra. J Neurol Neurosurg Psychiatry 67: 815-818
18. Hutchinson M, Raff U, Lebedev S (2003) MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM). Neuroimage 20: 1899-1902
19. Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J et al. (2005) Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 76: 672-680
20. Khan NL, Valente EM, Bentivoglio AR, Wood NW, Albanese A, Brooks DJ et al. (2002) Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol 52: 849-853
21. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55(3): 306-319
22. Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH (2005) Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 57(2): 176-179
23. Mattay VS, Tessitore A, Callicott JH, Bertolino A, Goldberg TE, Chase TN, Hyde TM, Weinberger DR (2002) Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51: 156-164
24. Naka H, Imon Y, Ohshita T, Honjo M, Kitamura T, Miyachi T, Katayama S, Mimori Y, Nakamura S (2002) Magnetization transfer measurements of brain structures in patients with multiple system atrophy. Neuroimage 17: 1572-1578
25. Nichols WC, Pankratz N, Hernandez D, Paisan-Ruiz C, Jain S, Halter CA et al. (2005) Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365: 410-412
26. O'Neill J, Schuff N, Marks WJ, Feiwell R, Aminoff MJ, Weiner MW (2002) Quantitative H-1 magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov Disord 17: 917-927
27. Ohshita T, Oka M, Imon Y, Yamaguchi S, Mimori Y, Nakamura S (2000) Apparent diffusion coefficient measurements in progressive supranuclear palsy. Neuroradiology 42: 643-647
28. Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol 57(2): 168-175
29. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der BM et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44: 595-600
30. Paisan-Ruiz C, Saenz A, de Munain AL, Marti I, Martinez GA, Marti-Masso JF et al. (2005) Familial Parkinson's disease: clinical and genetic analysis of four Basque families. Ann Neurol 57: 365-372
31. Paviour DC, Price SL, Stevens JM, Lees AJ, Fox NC (2005) Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 64: 675-679
32. Pujol J, Roset-Llobet J, Rosines-Cubells D, Deus J, Narberhaus B, Valls-Sole J, Capdevila A, Pascual-Leone A (2000) Brain cortical activation during guitar-induced hand dystonia studied by functional MRI. Neuroimage 12: 257-267
33. Samii A, Markopoulou K, Wszolek ZK, Sossi V, Dobko T, Mak E et al. (1999) PET studies of parkinsonism associated with mutation in the alpha-synuclein gene. Neurology 53: 2097-2102
34. Scherfler C, Khan NL, Pavese N, Eunson L, Graham E, Lees AJ et al. (2004) Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism. Brain 127: 1332-1342
35. Schocke MFH, Seppi K, Esterhammer R, Kremser C, Jaschke W, Poewe W, Wenning GK (2002) Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 58: 575-580
36. Schocke MFH, Seppi K, Esterhammer R, Kremser C, Mair KJ, Czermak BV, Jaschke W, Poewe W, Wenning GK (2004) Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 21: 1443-1451
37. Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, Lees AJ, Quinn NP (2000) Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 54: 697-702
38. Schulz JB, Skalej M, Wedekind D, Luft AR, Abele M, Voigt K, Dichgans J, Klockgether T (1999) Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 45: 65-74
39. Seppi K, Schocke MFH, Esterhammer R, Kremser C, Brenneis C, Mueller J, Boesch S, Jaschke W, Poewe W, Wenning GK (2003) Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 60: 922-927
40. Sohmiya M, Tanaka M, Aihara Y, Okamoto K (2004) Structural changes in the midbrain with aging and Parkinson's disease: an MRI study. Neurobiol Aging 25: 449-453
41. Summerfield C, Junque C, Tolosa E, Salgado-Pineda P, Gomez-Anson B, Marti M, Ramirez-Ruiz B, Mercader J (2005) Structural brain changes in Parkinson disease with dementia. Arch Neurol 62: 281-285
42. Vila M, Przedborski S (2004) Genetic clues to the pathogenesis of Parkinson's disease. Nat Med 10 (Suppl): S58-S62
43. Watanabe H, Fukatsu H, Katsuno M, Sugiura M, Hamada K, Okada Y, Hirayama M, Ishigaki T, Sobue G (2004) Multiple regional H-1-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry 75: 103-109
44. Yoshikawa K, Nakata Y, Yamada K, Nakagawa M (2004) Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 75: 481-484
45. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44: 601-607